
Results
30
Companies which have announced upcoming dividend payments.
30 companies
Jagsonpal Pharmaceuticals
Market Cap: ₹15.6b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹230.80
7D
4.1%
1Y
-14.9%
Abbott India
Market Cap: ₹585.8b
Operates as a pharmaceutical company in India.
500488
₹27,784.20
7D
-0.8%
1Y
-17.5%
Mercury Laboratories
Market Cap: ₹955.2m
Engages in manufacturing, selling, exporting, and dealing in various pharmaceutical drugs and medicines for mother and child healthcare in India and internationally.
538964
₹796.00
7D
-4.7%
1Y
-8.4%
Alembic Pharmaceuticals
Market Cap: ₹157.8b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹797.05
7D
-0.07%
1Y
-16.9%
Procter & Gamble Health
Market Cap: ₹107.9b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹6,597.45
7D
-1.9%
1Y
6.4%
Pfizer
Market Cap: ₹219.6b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,823.90
7D
4.3%
1Y
-4.6%
Jenburkt Pharmaceuticals
Market Cap: ₹4.8b
Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.
524731
₹1,076.90
7D
2.4%
1Y
-15.8%
Sun Pharmaceutical Industries
Market Cap: ₹4.8t
A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.
SUNPHARMA
₹1,990.50
7D
2.5%
1Y
22.1%
Alkem Laboratories
Market Cap: ₹695.4b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹5,751.50
7D
2.1%
1Y
17.4%
RPG Life Sciences
Market Cap: ₹45.9b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,768.20
7D
-5.7%
1Y
17.8%
BDH Industries
Market Cap: ₹3.2b
Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally.
524828
₹563.25
7D
-4.5%
1Y
86.4%
Granules India
Market Cap: ₹206.7b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹824.05
7D
-1.2%
1Y
82.4%
Bliss GVS Pharma
Market Cap: ₹48.2b
Engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally.
506197
₹467.40
7D
0.8%
1Y
169.1%
Divi's Laboratories
Market Cap: ₹2.1t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹8,056.00
7D
11.1%
1Y
26.6%
Lupin
Market Cap: ₹1.1t
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹2,413.95
7D
1.9%
1Y
29.4%
Strides Pharma Science
Market Cap: ₹98.9b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹1,025.00
7D
0.5%
1Y
22.5%
Fermenta Biotech
Market Cap: ₹13.3b
Manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally.
506414
₹501.25
7D
15.9%
1Y
38.5%
Syngene International
Market Cap: ₹158.9b
A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.
SYNGENE
₹385.90
7D
-5.1%
1Y
-45.1%
Hester Biosciences
Market Cap: ₹20.9b
Manufactures and trades in veterinary vaccines and health products in India and internationally.
524669
₹2,482.05
7D
5.0%
1Y
13.7%
Marksans Pharma
Market Cap: ₹117.2b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹258.35
7D
4.9%
1Y
14.9%
Concord Biotech
Market Cap: ₹139.1b
A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,420.80
7D
13.8%
1Y
-18.4%
Indegene
Market Cap: ₹124.0b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹515.15
7D
4.6%
1Y
-10.8%
Anuh Pharma
Market Cap: ₹7.9b
Engages in the manufacture and sale of bulk drugs and chemicals in India.
506260
₹79.25
7D
0.2%
1Y
-17.2%
Venus Remedies
Market Cap: ₹20.7b
Engages in the pharmaceutical business in India, Latin America, Europe, the Middle East, Africa, Asia, and internationally.
526953
₹1,566.60
7D
-5.1%
1Y
199.0%
Kopran
Market Cap: ₹9.0b
An integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally.
524280
₹191.85
7D
-3.5%
1Y
20.7%
Ipca Laboratories
Market Cap: ₹446.2b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.
IPCALAB
₹1,747.80
7D
-0.8%
1Y
20.5%
Smruthi Organics
Market Cap: ₹1.3b
Manufactures and markets active pharmaceutical ingredient (API) products to India.
540686
₹112.95
7D
-0.9%
1Y
-14.8%
TTK Healthcare
Market Cap: ₹14.2b
Engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India.
507747
₹1,024.75
7D
-2.3%
1Y
-18.7%
Windlas Biotech
Market Cap: ₹17.7b
A contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India.
WINDLAS
₹857.70
7D
-0.03%
1Y
-11.2%
Gland Pharma
Market Cap: ₹414.7b
Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
GLAND
₹2,502.90
7D
5.2%
1Y
26.5%